null

Human Papillomavirus (HPV) Antibodies, Proteins & ELISA Kits

Human Papillomavirus (HPV) Antibodies, Proteins & ELISA Kits | Assay Genie
Infectious Disease · Human papillomavirus

Human Papillomavirus (HPV) antibodies, proteins & ELISA kits

Human papillomavirus (HPV) is a DNA virus; persistent infection with high-risk types (notably 16 and 18) causes cervical and other cancers through the E6 and E7 oncoproteins.

HPVE6 / E7 / L1Oncogenic types
HPV
Papillomavirus
E6 / E7
Oncoproteins
16 & 18
High-risk types
L1
Vaccine antigen
Overview

What is Human Papillomavirus (HPV)?

Human papillomavirus (HPV) is a DNA virus; persistent infection with high-risk types (notably 16 and 18) causes cervical and other cancers through the E6 and E7 oncoproteins.

HPV is sexually transmitted. Research tools target the E6/E7 oncoproteins, the L1 capsid (the basis of prophylactic vaccines) and p16INK4a, supported by antibodies, proteins and ELISA kits.

Transmission & symptoms

HPV is a sexually transmitted DNA virus. Most infections clear, but persistent high-risk types (notably HPV-16 and -18) cause cervical and other anogenital and oropharyngeal cancers via the E6 and E7 oncoproteins, which inactivate p53 and retinoblastoma (Rb).

Diagnosis & serology

Screening combines HPV DNA/genotyping with cytology; the biomarker p16INK4a (CDKN2A) is a validated surrogate of transforming HPV infection. L1-based serology supports vaccine immunogenicity studies.

Research applications

Research tools target the E6/E7–p53/Rb axis, the p16INK4a biomarker, epithelial markers (E-cadherin) and L1 capsid antigens underpinning prophylactic HPV vaccines.

FAQs

Human Papillomavirus (HPV) — frequently asked questions

How does HPV cause cancer?
High-risk HPV E6 and E7 oncoproteins degrade p53 and inactivate retinoblastoma (Rb), driving unchecked proliferation and malignant transformation.
What is p16INK4a used for in HPV testing?
p16INK4a (CDKN2A) over-expression is a validated biomarker of transforming high-risk HPV infection and is widely used in cervical pathology research.
What do HPV vaccines target?
Prophylactic vaccines are based on the L1 capsid protein assembled into virus-like particles, eliciting neutralising antibodies.
Explore more

More Human Papillomavirus (HPV) research tools

Need a Human Papillomavirus (HPV) assay we don’t list?

Our PhD-level team can help you find the right kit, protein or antibody — or develop a custom assay for your target.

Talk to our team
Validated reagentsLinks checked & live7–10 day deliveryPhD-level support